GL

Guy J. Laidig

OT Onyx Therapeutics: 25 patents #1 of 49Top 3%
CB Calithera Biosciences: 4 patents #10 of 36Top 30%
PR Proteolix: 4 patents #1 of 12Top 9%
RP Rigel Pharmaceuticals: 1 patents #141 of 184Top 80%
📍 Menlo Park, CA: #213 of 3,774 inventorsTop 6%
🗺 California: #13,801 of 386,348 inventorsTop 4%
Overall (All Time): #98,542 of 4,157,543Top 3%
35
Patents All Time

Issued Patents All Time

Showing 26–35 of 35 patents

Patent #TitleCo-InventorsDate
8129346 Compounds for enzyme inhibition Mark S. Smyth, Ronald T. Borchardt, Barry A. Bunin, Craig M. Crews, John H. Musser 2012-03-06
8088741 Compounds for enzyme inhibition Mark S. Smyth, Ronald T. Borchardt, Barry A. Bunin, Craig M. Crews, John H. Musser +2 more 2012-01-03
8080545 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2011-12-20
8080576 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2011-12-20
7691852 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2010-04-06
7687456 Compounds for enzyme inhibition Han-Jie Zhou, Congcong M. Sun, Kevin D. Shenk 2010-03-30
7569580 Heterotricyclic compounds for use as HCV inhibitors Sambaiah Thota, Rajinder Singh, Henry Lu 2009-08-04
7491704 Compounds for enzyme inhibition Mark S. Smyth, Ronald T. Borchardt, Barry A. Bunin, Craig M. Crews, John H. Musser 2009-02-17
7417042 Compounds for enzyme inhibition Mark S. Smyth 2008-08-26
7232818 Compounds for enzyme inhibition Mark S. Smyth, Ronald T. Borchardt, Barry A. Bunin, Craig M. Crews, John H. Musser 2007-06-19